Abstract
Introduction:
Patients who develop a perineal hernia after abdominoperineal resection may experience discomfort during daily activities and urogenital dysfunction, but the impact on quality of life has never been formally assessed.
Materials and methods:
Patients who underwent abdominoperineal resection for rectal cancer between 2014 and 2022 in two prospective multicenter trials were included. Primary outcome was defined as median overall scores or scores on functional and symptom scales of the following quality of life questionnaires: 5-level version of the 5-dimensional EuroQol, Short Form-36, and European Organization for Research and Treatment of Cancer QoL Questionnaire Colorectal cancer 29 and 30, Urogenital Distress Inventory-6, Incontinence Impact Questionnaire-7.
Results:
Questionnaires were available in 27 patients with a perineal hernia and 62 patients without a perineal hernia. The 5-dimensional EuroQol score was significantly lower in patients with a perineal hernia (83 vs 87, p = 0.048), which implies a reduced level of functioning. The median scores of pain-specific domains were significantly worse in patients with a perineal hernia as measured by the SF-36 (78 vs. 90, p = 0.006), the EORTC-CR29 (17 vs. 11, p=<0.001) and EORTC-C30 (17 vs. 0, p = 0.019). Also, significantly worse physical (73 vs. 100, p = 0.049) and emotional (83 vs. 100, p = 0.048) functioning based on EORTC-C30 was observed among those patients. Minimally important differences were found for role, physical and social functioning of the SF-36 and EORTC-C30. The urological function did not differ between the groups.
Conclusion:
A symptomatic perineal hernia can significantly worsen quality of life on several domains, indicating the severity of this complication.
| Original language | English |
|---|---|
| Article number | 107114 |
| Number of pages | 5 |
| Journal | European Journal of Surgical Oncology |
| Volume | 49 |
| Issue number | 12 |
| DOIs | |
| Publication status | Published - Dec 2023 |
Bibliographical note
Funding Information:The data used in this cohort study was retrospectively obtained from the databases of two prospective trials which were funded by by LifeCell, an Allergan Company (NL42094.018.12), and by the Dutch Cancer Society (‘KWF Kankerbestrijding’) (NL65461.180.18). These funding sources did not influence the study designs nor the results of the trails.The data used in this cohort study was retrospectively obtained from the databases of two prospective trials which were funded by LifeCell, an Allergan Company (NL42094.018.12), and by the Dutch Cancer Society (‘KWF Kankerbestrijding’) (NL65461.180.18).The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: P.J. Tanis reports financial support was provided by Dutch Cancer Society. P.J. Tanis reports financial support was provided by LifeCell Corp.
Funding Information:
The data used in this cohort study was retrospectively obtained from the databases of two prospective trials which were funded by by LifeCell, an Allergan Company (NL42094.018.12), and by the Dutch Cancer Society (‘KWF Kankerbestrijding’) ( NL65461.180.18 ). These funding sources did not influence the study designs nor the results of the trails.
Funding Information:
The data used in this cohort study was retrospectively obtained from the databases of two prospective trials which were funded by LifeCell, an Allergan Company (NL42094.018.12), and by the Dutch Cancer Society (‘KWF Kankerbestrijding’) ( NL65461.180.18 ).
Publisher Copyright:
© 2023 The Authors
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Quality of life in patients with a perineal hernia'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver